{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:24:11Z","timestamp":1791228251738,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rmed.2026.108744","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:31:19Z","timestamp":1772483479000},"page":"108744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Bronchiectasis: Past insights, present clinical evidence, and future research pathways"],"prefix":"10.1016","volume":"254","author":[{"given":"Ramez M.","family":"Halaseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma'moon","family":"Al-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-2768","authenticated-orcid":false,"given":"Leela Krishna Teja","family":"Boppana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-4493","authenticated-orcid":false,"given":"Ali","family":"Al-Tarbsheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-1300","authenticated-orcid":false,"given":"Michael D.","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Salamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Hadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108744_bib3","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1183\/09031936.97.10122784","article-title":"Bronchiectasis: an orphan disease with a poorly-understood prognosis","volume":"10","author":"Keistinen","year":"1997","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2023.104174","article-title":"Bronchiectasis","volume":"52","author":"Barbosa","year":"2023","journal-title":"La Presse M\u00e9dicale"},{"issue":"174","key":"10.1016\/j.rmed.2026.108744_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0091-2024","article-title":"Epidemiology of bronchiectasis","volume":"33","author":"Nigro","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.108744_bib7","first-page":"6","article-title":"Inflammation: a two-edged sword--the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur. J. Respir. Dis. Suppl."},{"issue":"10150","key":"10.1016\/j.rmed.2026.108744_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"issue":"176","key":"10.1016\/j.rmed.2026.108744_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.108744_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108179","article-title":"Bronchiectasis: a clinical review of inflammation","volume":"244","author":"Doumat","year":"2025","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01126-2025","article-title":"European respiratory society clinical practice guideline for the management of adult bronchiectasis","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccm.2021.11.004","article-title":"Radiology of bronchiectasis","volume":"43","author":"Pakzad","year":"2022","journal-title":"Clin. Chest Med."},{"issue":"168","key":"10.1016\/j.rmed.2026.108744_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0015-2023","article-title":"Basic, translational and clinical aspects of bronchiectasis in adults","volume":"32","author":"Chalmers","year":"2023","journal-title":"Eur. Respir. Rev."},{"issue":"174","key":"10.1016\/j.rmed.2026.108744_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0087-2024","article-title":"Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects","volume":"33","author":"Spinou","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"16","key":"10.1016\/j.rmed.2026.108744_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clin. Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron. Respir. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.chest.2018.07.014","article-title":"Characteristics and health-care utilization history of patients with bronchiectasis in US medicare enrollees with prescription drug plans, 2006 to 2014","volume":"154","author":"Henkle","year":"2018","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108744_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rmed.2019.09.012","article-title":"Epidemiology of bronchiectasis in the UK: findings from the British lung foundation's \u2018Respiratory health of the nation\u2019 project","volume":"158","author":"Snell","year":"2019","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108744_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107167","article-title":"Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry","volume":"209","author":"McShane","year":"2023","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.chest.2023.06.040","article-title":"The economic burden of bronchiectasis","volume":"164","author":"Roberts","year":"2023","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0041-1730891","article-title":"Pathophysiology of bronchiectasis","volume":"42","author":"Keir","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.202405-0947ED","article-title":"A global effort to stop the vicious vortex: a special American journal of respiratory and critical care medicine issue for world bronchiectasis day 2024","volume":"210","author":"Shteinberg","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"173","key":"10.1016\/j.rmed.2026.108744_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and genomics of bronchiectasis","volume":"33","author":"Perea","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01050-2024","article-title":"Targeting neutrophil serine proteases in bronchiectasis","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.00212114","article-title":"Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis","volume":"46","author":"Garratt","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2026.108744_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis: a European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"16","key":"10.1016\/j.rmed.2026.108744_bib32","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3390\/jcm13164932","article-title":"Eosinophilic bronchiectasis: prevalence, severity, and associated features\u2014A cohort study","volume":"13","author":"Campisi","year":"2024","journal-title":"JCM"},{"issue":"173","key":"10.1016\/j.rmed.2026.108744_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2024","article-title":"Exacerbations of bronchiectasis","volume":"33","author":"De Angelis","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00408-023-00668-w","article-title":"Elevated eosinophil counts in acute exacerbations of bronchiectasis: unveiling a distinct clinical phenotype","volume":"202","author":"Chen","year":"2024","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaip.2022.10.027","article-title":"Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis","volume":"11","author":"Guan","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-Shaped relationship between eosinophil count and bronchiectasis severity","volume":"164","author":"Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.rmed.2026.108744_bib37","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.3390\/ijerph18168431","article-title":"Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: the role of eosinophils in disease severity","volume":"18","author":"Wang","year":"2021","journal-title":"IJERPH"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202403-0473PP","article-title":"The precision medicine era of bronchiectasis","volume":"210","author":"Chotirmall","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.202205-0860ED","article-title":"Microbiomics-focused data integration: a fresh solve for the Rubik's cube of endophenotyping?","volume":"206","author":"Narayana","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.rmed.2006.11.008","article-title":"Aetiology in adult patients with bronchiectasis","volume":"101","author":"Shoemark","year":"2007","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108744_bib42","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non\u2013cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni","year":"2015","journal-title":"Annals ATS"},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0119-2021","article-title":"Precision medicine in bronchiectasis","volume":"17","author":"Pembridge","year":"2021","journal-title":"Breathe"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12890-020-1080-7","article-title":"Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"18","key":"10.1016\/j.rmed.2026.108744_bib50","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.3390\/jcm12185782","article-title":"Etiology of bronchiectasis in the world: data from the published national and international registries","volume":"12","author":"G\u00f3mez-Olivas","year":"2023","journal-title":"JCM"},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177931","article-title":"Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish bronchiectasis historical registry","volume":"12","author":"De La Rosa","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150532","article-title":"Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Du","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13023-023-02830-2","article-title":"The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO","volume":"18","author":"Stockley","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0041-1730893","article-title":"Common variable immunodeficiency and other immunodeficiency syndromes in bronchiectasis","volume":"42","author":"McShane","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108744_bib53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3389\/fimmu.2020.00522","article-title":"Bronchiectasis in primary antibody deficiencies: a multidisciplinary approach","volume":"11","author":"Wall","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ppul.24599","article-title":"Bronchiectasis in common variable immunodeficiency: a systematic review and meta\u2010analysis","volume":"55","author":"Ramzi","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"8","key":"10.1016\/j.rmed.2026.108744_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055672","article-title":"Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006\u20132021: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"BMJ Open"},{"issue":"173","key":"10.1016\/j.rmed.2026.108744_bib77","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0058-2024","article-title":"Growing from common ground: nontuberculous mycobacteria and bronchiectasis","volume":"33","author":"Van Braeckel","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"11","key":"10.1016\/j.rmed.2026.108744_bib78","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1016\/j.ijid.2013.03.018","article-title":"Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis","volume":"17","author":"Mirsaeidi","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Clin. Chest Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.chest.2024.06.3843","article-title":"Aspergillus serologic findings and clinical outcomes in patients with bronchiectasis","volume":"167","author":"Pollock","year":"2025","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MCP.0000000000000755","article-title":"Obstructive lung diseases and allergic bronchopulmonary aspergillosis","volume":"27","author":"Muthu","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib71","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00176-2022","article-title":"Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis","volume":"60","author":"Shoemark","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib72","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.chest.2024.05.023","article-title":"Primary ciliary dyskinesia in adult bronchiectasis","volume":"166","author":"Ewen","year":"2024","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ppul.23304","article-title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review","volume":"51","author":"Shapiro","year":"2016","journal-title":"Pediatr. Pulmonol."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2026.108744_bib62","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/resp.13615","article-title":"Paediatric and adult bronchiectasis: specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel disease","volume":"24","author":"Maglione","year":"2019","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0039-1684029","article-title":"Histology of pulmonary and bronchiolar disorders in connective tissue diseases","volume":"40","author":"Brambilla","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mayocp.2018.09.002","article-title":"Interstitial lung disease and other pulmonary manifestations in connective tissue diseases","volume":"94","author":"Mira-Avendano","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"19","key":"10.1016\/j.rmed.2026.108744_bib68","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3390\/jcm12196419","article-title":"Lung involvement in inflammatory bowel diseases: shared pathways and unwanted connections","volume":"12","author":"Cavalli","year":"2023","journal-title":"JCM"},{"key":"10.1016\/j.rmed.2026.108744_bib83","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.rmed.2018.06.031","article-title":"A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: current understanding and future risk","volume":"141","author":"McDonnell","year":"2018","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1513\/AnnalsATS.201906-427CME","article-title":"Reflux-aspiration in chronic lung disease","volume":"17","author":"Lee","year":"2020","journal-title":"Annals ATS"},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib85","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cgh.2023.01.040","article-title":"AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review","volume":"21","author":"Chen","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.rmed.2026.108744_bib80","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1164\/rccm.200703-489OC","article-title":"Prevalence and impact of bronchiectasis in \u03b11 -Antitrypsin deficiency","volume":"176","author":"Parr","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"18","key":"10.1016\/j.rmed.2026.108744_bib81","first-page":"6569","article-title":"Young's syndrome, a rare syndrome that can cause infertility and mimics cystic fibrosis and immotile-cilia syndrome: a case report","volume":"26","author":"Cihanbeylerden","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib82","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/thx.47.3.184","article-title":"Mucociliary function, ciliary ultrastructure, and ciliary orientation in Young's syndrome","volume":"47","author":"de Iongh","year":"1992","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.rmed.2026.108744_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the european bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1183\/23120541.00775-2020","article-title":"BronchUK: protocol for an observational cohort study and biobank in bronchiectasis","volume":"7","author":"De Soyza","year":"2021","journal-title":"ERJ Open Res."},{"issue":"7","key":"10.1016\/j.rmed.2026.108744_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","article-title":"Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study","volume":"107","author":"Anwar","year":"2013","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population","volume":"142","author":"McShane","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12890-023-02543-z","article-title":"Etiology and clinical characteristics of a non-cystic fibrosis bronchiectasis cohort in a middle Eastern population","volume":"23","author":"Shafiq","year":"2023","journal-title":"BMC Pulm. Med."},{"issue":"11","key":"10.1016\/j.rmed.2026.108744_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/resp.13509","article-title":"Pathophysiology, causes and genetics of paediatric and adult bronchiectasis","volume":"24","author":"Bush","year":"2019","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.rmed.2026.108744_bib55","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1007\/s10875-023-01593-6","article-title":"Respiratory comorbidities associated with bronchiectasis in patients with common variable immunodeficiency in the USIDNET registry","volume":"43","author":"Correa-Jimenez","year":"2023","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/cei.13595","article-title":"Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand common variable immunodeficiency disorders cohort study","volume":"204","author":"Ameratunga","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chest.2021.07.2165","article-title":"High frequency of allergic bronchopulmonary aspergillosis in Bronchiectasis-COPD overlap","volume":"161","author":"Tiew","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108744_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2025.03.014","article-title":"Bronchiectasis in patients with inflammatory bowel diseases \u2013 prevalence, predictors, and clinical characteristics","author":"Freund","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108744_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1447716","article-title":"Prevalence of bronchiectasis in inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Ma","year":"2024","journal-title":"Front. Med."},{"issue":"143","key":"10.1016\/j.rmed.2026.108744_bib73","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0058-2016","article-title":"Diagnosis of primary ciliary dyskinesia: potential options for resource-limited countries","volume":"26","author":"Rumman","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"8","key":"10.1016\/j.rmed.2026.108744_bib74","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1164\/rccm.201301-0059CI","article-title":"Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease","volume":"188","author":"Knowles","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12879-016-1774-x","article-title":"Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study","volume":"16","author":"M\u00e1iz","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib86","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib87","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00558-2020","article-title":"Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population","volume":"56","author":"\u00c7olak","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108744_bib88","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-med-042120-020148","article-title":"Clinical phenotypes of cystic fibrosis carriers","volume":"73","author":"Polgreen","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108744_bib89","doi-asserted-by":"crossref","first-page":"ofae024","DOI":"10.1093\/ofid\/ofae024","article-title":"Cystic fibrosis carrier states are associated with more severe cases of bronchiectasis","volume":"11","author":"Miller","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccm.2021.11.001","article-title":"Diagnosis and evaluation of bronchiectasis","volume":"43","author":"Cohen","year":"2022","journal-title":"Clin. Chest Med."},{"issue":"149","key":"10.1016\/j.rmed.2026.108744_bib91","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0016-2018","article-title":"Bronchiectasis: a case-based approach to investigation and management","volume":"27","author":"Contarini","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib96","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00408-024-00707-0","article-title":"Type 2 biomarkers and their clinical implications in bronchiectasis: a prospective cohort study","volume":"202","author":"Chen","year":"2024","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.rmed.2026.108744_bib133","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/biom12101399","article-title":"Peripheral neutrophil-to-lymphocyte ratio in bronchiectasis: a marker of disease severity","volume":"12","author":"Martinez-Garc\u00eda","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.rmed.2026.108744_bib134","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/1440-1681.13331","article-title":"The association between serum albumin\/prealbumin level and disease severity in non\u2010CF bronchiectasis","volume":"47","author":"Li","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.rmed.2026.108744_bib135","doi-asserted-by":"crossref","DOI":"10.1177\/14799731211017548","article-title":"Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis","volume":"18","author":"Ju","year":"2021","journal-title":"Chron. Respir. Dis."},{"key":"10.1016\/j.rmed.2026.108744_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2019.01.009","article-title":"Vitamin D and disease severity in bronchiectasis","volume":"148","author":"Ferri","year":"2019","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib137","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thoraxjnl-2012-202125","article-title":"Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis","volume":"68","author":"Chalmers","year":"2013","journal-title":"Thorax"},{"issue":"156","key":"10.1016\/j.rmed.2026.108744_bib92","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0120-2019","article-title":"The radiological diagnosis of bronchiectasis: what's in a name?","volume":"29","author":"Tiddens","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib93","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221109","article-title":"Artificial intelligence\u2013based CT assessment of bronchiectasis: the COPDGene study","volume":"307","author":"D\u00edaz","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib94","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.7861\/clinmed.2021-0651","article-title":"Diagnosis and management of non-cystic fibrosis bronchiectasis","volume":"21","author":"Macfarlane","year":"2021","journal-title":"Clin. Med."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2026.108744_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"T Hill","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib97","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2022","article-title":"European respiratory society statement on airway clearance techniques in adults with bronchiectasis","volume":"62","author":"Herrero-Cortina","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib98","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Mu\u00f1oz","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib99","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.00055509","article-title":"A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib119","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00518-2024","article-title":"Bronchiectasis management in adults: state of the art and future directions","volume":"63","author":"Choi","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108744_bib101","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir. Med."},{"issue":"16","key":"10.1016\/j.rmed.2026.108744_bib102","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","article-title":"Hypertonic saline or carbocisteine in bronchiectasis","volume":"393","author":"Bradley","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108744_bib103","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib104","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib117","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0041-1730945","article-title":"Long-term antibiotics in bronchiectasis","volume":"42","author":"Suarez-Cuartin","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.108744_bib118","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib106","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00608-2020","article-title":"Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a Post Hoc analysis of the AIR-BX studies","volume":"56","author":"Crichton","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib107","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"Respire 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib108","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"Respire 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib109","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","article-title":"A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection","volume":"163","author":"Guan","year":"2023","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib110","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01451-2020","article-title":"Efficacy and safety of TOBI podhaler in Pseudomonas aeruginosa- infected bronchiectasis patients: iBEST study","volume":"57","author":"Loebinger","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2026.108744_bib113","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMra2202819","article-title":"Bronchiectasis \u2014 a clinical review. Taichman DB","volume":"387","author":"O'Donnell","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"171","key":"10.1016\/j.rmed.2026.108744_bib116","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0178-2023","article-title":"Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis","volume":"33","author":"Concei\u00e7\u00e3o","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"9","key":"10.1016\/j.rmed.2026.108744_bib120","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jaip.2023.05.041","article-title":"Real-world effectiveness of IL-5\/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis","volume":"11","author":"Bendien","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.rmed.2026.108744_bib132","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"22","key":"10.1016\/j.rmed.2026.108744_bib122","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib123","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108744_bib124","unstructured":"The AIRTIVITYTM Study: A study to find out whether BI 1291583 helps people with bronchiectasis. ClinicalTrialsID: NCT06872892. Accessed January 18, 2026. https:\/\/clinicaltrials.gov\/study\/NCT06872892."},{"issue":"5","key":"10.1016\/j.rmed.2026.108744_bib127","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.108744_bib105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.108744_bib111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-2600(24)00225-X","article-title":"Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months","volume":"12","author":"Haworth","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108744_bib115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"176","key":"10.1016\/j.rmed.2026.108744_bib125","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0257-2024","article-title":"Dipeptidyl peptidase-1 inhibitors in bronchiectasis","volume":"34","author":"Johnson","year":"2025","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.rmed.2026.108744_bib126","first-page":"277","article-title":"Periodontal effects of the reversible dipeptidyl peptidase 1 inhibitor brensocatib in bronchiectasis","volume":"9","author":"Gunsolley","year":"2024","journal-title":"JDR Clin. Transl. Res."},{"issue":"21","key":"10.1016\/j.rmed.2026.108744_bib128","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor\u2013ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108744_bib129","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A4127","article-title":"Recurrent bronchiectasis exacerbations in single Phe508del mutation carriers: time to treat as adult cystic fibrosis?","volume":"211","author":"Ebrahimi","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108744_bib130","article-title":"Treating non-cystic fibrosis bronchiectasis with CFTR modulators: early case reports","volume":"9","author":"Swenson","year":"2024","journal-title":"Ann Case Rep."},{"key":"10.1016\/j.rmed.2026.108744_bib131","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00007-2025","article-title":"Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in non-cystic fibrosis bronchiectasis patients with a single pathogenic CFTR mutation: a retrospective cohort analysis","author":"Papadakis","year":"2025","journal-title":"ERJ Open Res."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:15:17Z","timestamp":1774358117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":136,"alternative-id":["S0954611126001125"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108744","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis: Past insights, present clinical evidence, and future research pathways","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108744"}}